Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2141 N Harbor Blvd. Suite 3200
Fullerton, CA 92835
Summary
- Dr. David Park is an oncologist in Fullerton, CA and is affiliated with Providence St. Jude Medical Center. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 18 years. He specializes in gastrointestinal cancer, head & neck cancer, and thoracic cancer and is experienced in glioblastoma, breast cancer, and phase 1 clinical trials.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2005 - 2006- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2004 - 2005
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2001 - 2003
Icahn School of Medicine at Mount SinaiClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Hospice and Palliative Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Publications & Presentations
PubMed
- 109 citationsERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.David J. Park, Wu Zhang, Jan Stoehlmacher, Denice D. Tsao-Wei, Susan Groshen
Clinical Advances in Hematology & Oncology. 2003-03-01 - 26 citationsThe role of proteasome inhibitors in solid tumors.David J. Park, Heinz-Josef Lenz
Annals of Medicine. 2004-01-01 - 32 citationsBone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosin...Amy L Lightner, Vikram Sengupta, Sascha Qian, John T Ransom, Sam Suzuki
Chest. 2023-12-01
Press Mentions
Mental Health Distress Can Affect Cancer Outcomes: Here’s Where You Can Find HelpDecember 9th, 2021
XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer StudyJuly 3rd, 2022- Aided by Community Health Workers, People with Advanced Cancer Need Fewer Hospital VisitsAugust 2nd, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
